Info

OTCQB Podcast

OTC Markets Group podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market.
RSS Feed
OTCQB Podcast
2024
November
October
September
August
July
June
May
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February


2017
December
November
October
September
August
July
June
May
April
March
January


Categories

All Episodes
Archives
Categories
Now displaying: August, 2017
Aug 29, 2017

100,000 patients in the U.S. have ascites due to advanced liver cirrhosis, with no approved drug to treat ascites. Jonathan Adams, CEO & CFO of BioVie Inc. (OTCQB: BIVI) discusses how the company is developing what they hope to be the first ever approved drug to treat ascites.

Aug 10, 2017

While in LA for the latest LD Micro conference, we had chance to speak with William Waldrop, CEO of Signal Bay, Inc. (OTCQB: SGBY) which owns Signal Bay Research, Signal Bay Services and EVIO labs. Listen in to learn more about the latest developments in research, consulting and testing services for the legal cannabis industry.

1